THE 30-SECOND OVERVIEW
GLOW peptide blend quick start
GLOW combines GHK-Cu, BPC-157 and TB-500. Start with the formulation: the Stemcode GLOW vial contains 30 mg total in a 4:1:1 ratio.
30 mg total
20 mg GHK-Cu + 5 mg BPC-157 + 5 mg TB-500 per vial.
Not established
No validated human dosing frequency for this combination.
Vial ≠ daily dose
The amount on the label is the entire vial’s content.
Ratio comes first
GHK-Cu is two-thirds of the blend; each other peptide is one-sixth.
This guide explains research evidence and concentration arithmetic. It does not provide a self-administration protocol.
CALCULATE COMPONENT AMOUNTS
GLOW peptide dosage calculator
Calculate the amount of each peptide in a laboratory sample of the 30 mg blend. Enter the final solution volume, not the vial’s container capacity.
Enter positive volumes; the sample cannot exceed the final solution volume.
- GHK-Cu
- 666.7 mcg
- BPC-157
- 166.7 mcg
- TB-500
- 166.7 mcg
Illustrative arithmetic only. These inputs are not recommended preparation volumes or doses. No route, schedule or suitability for human use is implied.
The formula: component mass per vial ÷ final solution volume × sample volume. For other vial strengths, use the peptide calculator. Product specifications: GLOW blend 30 mg.
01 / TIMING
GLOW peptide dosage frequency
There is no established human dosing frequency for the GLOW blend. An online schedule described as “daily” or “five days on, two days off” is not the same as a schedule validated in a clinical trial.
For a laboratory protocol, frequency is a study-design variable. It depends on the experimental model, exposure duration and measured endpoint. Findings about one component cannot determine how often a three-component blend should be administered to people.
Does the cited study use the same peptide, the same blend ratio, the same experimental model and the same route? If any differ, its schedule does not establish a GLOW protocol.
02 / AMOUNT
GLOW peptide dose per day
A clinically established daily dose for GLOW is not available. In particular, 30 mg per vial does not mean 30 mg per day. It is the sum of three different component masses.
At the Stemcode 4:1:1 ratio, a hypothetical 1 mg laboratory sample contains approximately 667 micrograms of GHK-Cu, 167 micrograms of BPC-157 and 167 micrograms of TB-500. Those numbers describe composition, not a recommended daily amount.
Use the dosage calculator above to inspect component amounts for a chosen sample volume. For the individual copper peptide literature, see our GHK-Cu dosage research guide.
03 / FORMULATION
What’s in the GLOW vial?
The name “GLOW” alone does not specify a concentration. Check the actual product label before comparing any dosing tables.
| Peptide | Per vial | Share of blend |
|---|---|---|
| GHK-Cu | 20 mg | 66.67% |
| BPC-157 | 5 mg | 16.67% |
| TB-500 | 5 mg | 16.67% |
| Total GLOW blend | 30 mg | 100% |
The Glow peptide nasal spray is a separate formulation: 8 mg of each component, 24 mg total. Its 1:1:1 ratio differs from the vial’s 4:1:1 ratio. Do not transfer vial calculations to the nasal spray.
KLOW also differs: it adds KPV and changes the component amounts. See the separate KLOW dosage guide for its 80 mg formulation. Read the KLOW vs. GLOW comparison for the formulation details.
05 / THE EVIDENCE
What the research can—and cannot—tell us
Research on the individual components does not validate a daily dose, schedule or treatment outcome for their combination. FDA’s reviews identify limitations in human safety data and concerns including immunogenicity and peptide-related impurities.
The FDA’s BPC-157 briefing and TB-500 briefing provide primary-source context. The agency also discusses injectable GHK-Cu on its peptide safety-risk page.
Laboratory purity results document a tested sample; they do not demonstrate clinical safety or effectiveness. Review the GLOW vial’s specifications and available COA for product information. Follow documented laboratory handling requirements and our peptide storage guide.
QUICK ANSWERS
GLOW dosage FAQ
What is the GLOW peptide dose per day?
An established human daily dose for the GLOW combination is not available. The 30 mg figure describes the contents of the entire vial, not a daily dose. Component amounts can be calculated from a laboratory sample volume, but those calculations do not establish a safe human dose.
How often is GLOW peptide used?
No validated dosing frequency has been established for the GLOW blend in humans. Once-daily and cycling schedules discussed online should not be confused with clinical evidence. Research frequency depends on the specific study design.
Is the 30 mg vial the same as the Glow nasal spray?
No. The Stemcode GLOW vial contains 20 mg GHK-Cu, 5 mg BPC-157 and 5 mg TB-500. The Glow nasal spray contains 8 mg of each component, 24 mg total. Their ratios and delivery formats differ.
Does GLOW contain KPV?
No. GLOW combines GHK-Cu, BPC-157 and TB-500. KLOW adds KPV and has a different composition. A KLOW dosing table cannot be transferred to a GLOW vial.
How does SAVE25 work?
Use the Save 25% & add vial button on this page. The offer applies automatically to the GLOW 30 mg vial in your cart and carries through to secure checkout. Other products are excluded. Shipping and tax are calculated separately.
